| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |